HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by PIVER, M S. Articles by BARLOW, J. Search for Related Content PubMed PubMed Citation Articles by PIVER, M S. Articles by BARLOW, J.

Preoperative and Intraoperative Evaluation in Ovarian Malignancy

From the Department of Gynecology at Roswell Park Memorial Institute, Buffalo, New York

Abstract

The survival rate for patients with all stages of ovarian cancer has nut improved over the past quarter of a century. A review of 100 consecutive patients treated for ovarian cancer was undertaken to evaluate preoperative and intraoperative measures. The study revealed that one-third of patients had only physical examination, other than routine preoperative tests, prior to laparotomy, and that 11% did not have a pelvic examination. Eighty-three percent of the incisions were inadequate for evaluation of the upper abdomen for sites of other primary malignancies that could metastasize to the ovary and mimic ovarian cancer, or for evaluating known sites of metastasis from ovarian cancer such as the diaphragm, liver, and upper aortic lymph nodes. Specifically, the aortic nodes were not described in 92% of reports, the diaphragm in 84%, the stomach in 76%, the pancreas in 76%, the colon in 70%, and the liver in 59%. The ovary w as not resected or biopsied for histologic confirmation in one-third of the cases. It is proposed that the efficacious use of adjuvant therapy for women with ovarian cancer must be preceded by careful preoperative and intraoperative evaluation of all women with presumed ovarian malignancy.

This article has been cited by other articles:

				C. N. Krasner, M. Roche, N. S. Horowitz, J. G. Supko, S. I. Lee, and E. Oliva Case 11-2006 -- A 54-Year-Old Woman with a Mass in the Pelvis N. Engl. J. Med., April 13, 2006; 354(15): 1615 - 1625. [Full Text] [PDF]

				A. T. Baron, C. H. Boardman, J. M. Lafky, A. Rademaker, D. Liu, D. A. Fishman, K. C. Podratz, and N. J. Maihle Soluble Epidermal Growth Factor Receptor (SEG-FR) and Cancer Antigen 125 (CA125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 306 - 318. [Abstract] [Full Text] [PDF]